CORAT Therapeutics GmbH

General Information

Company Name

Founded Year

2020

Location (Offices)

Brunswick, Germany +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health and Wellness

Funding Stage

Corporate Round

Social Media

CORAT Therapeutics GmbH - Company Profile

CORAT Therapeutics GmbH is a biotechnology startup based in Germany, founded in 2020. The company's mission, as reflected in its slogan "Fighting COVID-19 with fully human neutralizing antibodies," is to develop phage-display derived fully human antibodies into passive vaccines to treat and to protect against COVID-19. Its focus on addressing the pressing global issue of the COVID-19 pandemic positions it as a relevant and potentially impactful player in the biotechnology space.

The company's most recent funding round, a Corporate Round investment at 07 July 2021, was led by Dermapharm. This injection of capital indicates a significant vote of confidence from an established player in the industry and infuses CORAT Therapeutics GmbH with the resources needed to further its research and development efforts.

Given the urgency and importance of finding effective solutions to combat COVID-19, the company's focus on fully human neutralizing antibodies presents an intriguing and potentially impactful approach. The recent investment from Dermapharm further validates the potential of CORAT Therapeutics GmbH and its innovative approach to addressing the ongoing global healthcare crisis.

Taxonomy: COVID-19, antibodies, vaccines, phage-display, treatment, protection, neutralizing antibodies, pharmaceuticals